Gaetano Giammona

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., Mero S.r.l., Novagenit S.r.l.. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaetano Giammona. Retrieved from https://idiyas.com/inventor/gaetano-giammona

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 25(Granted Patents)

Company Filing History:

4 out of 6

Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l.

Universita' Degli Studi Di Palermo

where one patent can have more than one assignee

Years Active: 2013-2023

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11633356 - Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases (2023-04-25),

2. 11285136 - Nanoparticles for controlled release of Sorafenib and Sorafenib derivatives (2022-03-29),

3. 11266659 - Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases (2022-03-08),

4. 11253526 - Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases (2022-02-22),

5. 10709787 - Hydrogels of methacrylic hyaluronic acid derivatives for oral enzyme therapy in celiac disease (2020-07-14),

6. 9410000 - Method to produce hyaluronic acid functionalized derivatives and formation of hydrogels (2016-08-09),

7. 9283283 - Hyaluronic acid based hydrogel and use thereof in surgery (2016-03-15),

8. 8858999 - Method to produce hyaluronic acid functionalized derivatives and formation of hydrogels thereof (2014-10-14),

9. 8529935 - Antibacterial hydrogel and use thereof in orthopedics (2013-09-10),

Title: Gaetano Giammona: Innovator in Ocular Disease Treatments

Introduction

Gaetano Giammona is a prominent inventor based in Palermo, Italy. He has made significant contributions to the field of ocular disease treatments, holding a total of 9 patents. His innovative work focuses on the development of advanced formulations for drug delivery, particularly in the treatment of neurodegenerative ocular diseases.

Latest Patents

One of Giammona's latest patents involves nanostructured formulations for the delivery of silibinin and other active ingredients aimed at treating ocular diseases. These formulations utilize lipid nanoparticle systems, including solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), which are designed to enhance the bioavailability of poorly soluble compounds. The versatility of calixarene compounds is highlighted, showcasing their ability to encapsulate and release active ingredients effectively.

Another notable patent describes nanoparticles for the controlled release of Sorafenib and its derivatives. These polymeric nanoparticles are engineered to provide a sustained release of the drug, which is crucial for treating various tumor diseases, including those affecting the kidney, liver, and brain. This innovative approach aims to improve therapeutic outcomes for patients suffering from these conditions.

Career Highlights

Throughout his career, Giammona has worked with several organizations, including the Distretto Tecnologico Sicilia Micro E Nano Sistemi and Mero S.r.l. His experience in these companies has allowed him to refine his expertise in nanotechnology and drug delivery systems, contributing to his success as an inventor.

Collaborations

Giammona has collaborated with notable colleagues such as Giovanna Pitarresi and Fabio Salvatore Palumbo. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of research in ocular treatments.

Conclusion

Gaetano Giammona's work in the field of ocular disease treatments exemplifies the impact of innovative thinking in medicine. His patents reflect a commitment to improving patient care through advanced drug delivery systems. His contributions continue to pave the way for future advancements in the treatment of ocular diseases.

Profile summary based on public USPTO records.